DCGN
Market cap now <90 mil, EV ~270 mil. As I watch the share value circle the drain, it is hard to find an amusing side to the investment.
The following was, however, irresistible (from the YMB):
DeCode's discovery of the NR1 gene for schizophrenia some years ago is what this company is ALL about. Schizophrenia drugs are used for a lifetime.
My guess is that DeCode may have one new drug in the works for this application. That alone makes holding this stock almost like holding a MegaMillions lottery with only one digit unknown.
Goldman Sachs knows it. Heck, I read where the entire Icelandic currency was being shorted so that DeCode can't use the loan from the Icelandic people......that's HOW BAD BIG MONEY really wants this company!!
